ArticlebioRxiv : the preprint server for biology2026
L-DOPA treatment promotes sustained neurovascular and synaptic homeostasis in the diabetic retina.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
While previous work has shown a sustained protective effect of levodopa (L-DOPA) on retinal function in early-stage diabetic retinopathy (DR) in humans, its underlying biology is unknown. Using noninvasive measures in diabetic mice, we found L-DOPA protects retinal neurovascular function as measured by oscillatory potential timing and flicker-evoked retinal vasodilation, as well as visual behavior, for at least two weeks past treatment end. Assessing changes in retinal gene expression, differentially expressed genes were broadly comparable between diabetic mice experiencing washout of L-DOPA versus continued L-DOPA treatment, with gene co-expression network analysis identifying distinct modules across L-DOPA-treated diabetic mice associated with synaptic function and cytoskeletal organization that correlated with functional protection. Together, these findings demonstrate that L-DOPA restores and sustains retinal neurovascular function in early DR and links this protection to transcriptional programs supporting synapse activity and structural integrity.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.